ResearcherUniversity of VirginiaActive in the last 2 years

Elio R. Bitar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0027-8446; OpenAlex author ID A5052934772. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

Toward Biologic Resectability in Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2026.3850 ↗
Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. Co-author DOI 10.1016/j.surg.2026.110256 ↗
Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race. Co-author DOI 10.1002/cam4.71346 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Samantha M. Ruff · 2 shared papers, 2025–2026 · strength 0.56
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗
- Paper Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race. DOI 10.1002/cam4.71346 ↗
Mohamad N. El Moheb · 2 shared papers, 2025–2026 · strength 0.56
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗
- Paper Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race. DOI 10.1002/cam4.71346 ↗
Allan Tsung · 2 shared papers, 2025–2026 · strength 0.56
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗
- Paper Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race. DOI 10.1002/cam4.71346 ↗
Allan Tsung · 1 shared paper, 2026 · strength 0.50
- Paper Toward Biologic Resectability in Pancreatic Cancer. DOI 10.1001/jamasurg.2026.3850 ↗
Olivia Sears · 1 shared paper, 2026 · strength 0.32
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.